zintick

Warby Parker WRBY

Warby Parker Inc. · NYSE · Ophthalmic Goods

$30.15+0.84%close on Nov. 11, 2026 · volume 5.0M · Yahoo Finance

Price, last 57 sessions

$22.50$25.00$27.50$30.00Sept. 2026Oct. 2026Nov. 2026
Aug. 24, 2026 to Nov. 11, 2026 · high $30.21 · low $21.29 · SEC filing, placed when SEC released it

Our coverage

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Oct. 1, 2026Jeffrey Jacob Raider
director
Sold
10b5-1 plan
15,000$27.70$415,500
Oct. 1, 2026Neil Harris Blumenthal
Co-Chief Executive Officer, director
Sold
10b5-1 plan
100,000$27.69$2.77 million

Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 11 →
  • 4Nov. 5, 2026, 6:05 p.m. ETView on SEC.gov
  • 10-QNov. 5, 2026, 4:26 p.m. ETView on SEC.gov
  • 8-KNov. 5, 2026, 6:46 a.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits

    AI summary, unreviewedWarby Parker Q3 2026 EPS of $0.04 misses $0.093 consensus as revenue of $244.7 million is roughly in line; full-year revenue guidance narrowed to $966-$976 million

  • 4Oct. 2, 2026, 5:09 p.m. ETView on SEC.gov
  • 4Oct. 2, 2026, 5:08 p.m. ETView on SEC.gov
  • 4Sept. 4, 2026, 4:47 p.m. ETView on SEC.gov
  • 4Sept. 4, 2026, 4:48 p.m. ETView on SEC.gov
  • 4Aug. 14, 2026, 4:11 p.m. ETView on SEC.gov